Trump's drug-stock holdings reportedly rose to as much as $56.2 million by the end of 2025

The Economic Times reports that congressional Democrats put Trump's pharmaceutical holdings at up to $56.2 million at the end of 2025, versus a maximum reported value of $1.7 million in 2024. Their report says up to $39.1 million was in companies benefiting from exemptions to Medicare drug-price negotiations under a 2025 Republican-backed law. Democrats also identified up to $2.55 million in purchases of those companies' shares before Trump signed the law in July 2025.